ConvaTec Group PLC Director/PDMR Shareholding (1280H)

TIDMCTEC

RNS Number : 1280H

ConvaTec Group PLC

30 July 2021

30 July 2021

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 30 July 2021, Professor Constantin Coussios, Non-Executive Director and a PDMR, purchased 8,440 Shares at GBP2.356227 per share. His resulting shareholding is 8,440 Shares.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
  1       Details of the person discharging managerial responsibilities/person 
           closely associated 
  a)     Name                                              Professor Constantin Coussios 
  2      Reason for the notification 
  a)     Position/Status                                   Non-Executive Director 
  b)     Initial notification/Amendment                    Initial notification 
  3      Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
  a)     Name                                              ConvaTec Group Plc 
  b)     LEI                                               213800LS272L4FIDOH92 
  4      Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
  a)     Description of the financial                      Ordinary shares of 10p each in ConvaTec Group Plc 
          instrument, type of instrument                   ("Shares") 
          Identification code                              GB00BD3VFW73 
  b)     Nature of the transaction                          Purchase of Shares on 30 July 2021 
  c)     Price(s) and volume(s)                            Price(s)                                        Volume(s) 
                                                            2.356227                                        8,440 
  d)     Aggregated information 
    - Aggregated volume                                     8,440 
    - Price                                                  19,886.56 
  e)     Date of the transaction                           2021-07-30 
  f)     Place of the transaction                          London Stock Exchange, Main Market (XLON) 
 
 

Enquiries

Analysts and Investors

   Kate Postans, VP of IR & Corporate Communications                          [phone] 

[e-mail]

Media

   Buchanan: Charles Ryland / Chris Lane / Vicky Hayns                         [phone] 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFSSDFIIVIL

(END) Dow Jones Newswires

July 30, 2021 10:45 ET (14:45 GMT)